What causes kbg syndrome

Overview

Kabuki syndrome (KS) is a rare, multisystem genetic disorder that presents with a recognizable facial phenotype, intellectual disability, developmental delay, and a variety of other physical and medical problems. The syndrome's name, 'Kabuki,' originates from the resemblance of the facial features to those of actors in traditional Japanese Kabuki theater. While the exact prevalence is not precisely known, it is considered a rare disorder, with estimates suggesting it affects roughly 1 in 86,000 to 1 in 120,000 newborns worldwide.

The spectrum of symptoms and their severity can vary significantly among affected individuals, making diagnosis and management challenging. Understanding the underlying causes of Kabuki syndrome is crucial for providing appropriate care and support to individuals and their families.

Causes of Kabuki Syndrome

Kabuki syndrome is primarily caused by genetic mutations, meaning changes in an individual's DNA. These mutations affect genes that are essential for normal development, particularly those involved in regulating gene expression. Gene expression is the process by which the information encoded in a gene is used to create a functional product, such as a protein. In Kabuki syndrome, these regulatory processes are disrupted, leading to a cascade of developmental issues.

Genetic Basis

The vast majority of Kabuki syndrome cases are caused by mutations in one of two genes:

• KMT2D (Lysine Methyltransferase 2D): This is the most frequently implicated gene, responsible for approximately 75% of all diagnosed cases of Kabuki syndrome. The KMT2D gene provides instructions for making an enzyme that plays a critical role in regulating gene expression through a process called 'histone methylation.' Histones are proteins that DNA wraps around, and methylation of histones can affect how tightly DNA is packed, thereby influencing which genes are turned on or off. Disruptions in KMT2D function can lead to widespread developmental problems.

• KMT2C (Lysine Methyltransferase 2C): Mutations in the KMT2C gene are responsible for a smaller percentage of cases, estimated to be around 5-10%. Similar to KMT2D, the KMT2C gene also encodes an enzyme involved in epigenetic regulation, specifically in modifying chromatin structure to control gene expression. While its role is similar to KMT2D, mutations in KMT2C can lead to a slightly different presentation or severity of symptoms in some individuals.

It is important to note that while KMT2D and KMT2C are the most common culprits, other genes have also been identified in a small number of Kabuki syndrome cases. These include genes like ARID1B, ADNP, and others. The identification of these additional genes underscores the complex genetic architecture underlying the syndrome.

Inheritance Patterns

In most instances, Kabuki syndrome arises from a de novo mutation. This means the genetic change occurs spontaneously in the affected individual and is not inherited from either parent. De novo mutations are common in genetic disorders and can occur at any point during the formation of egg or sperm cells or in early embryonic development. Consequently, parents of a child with Kabuki syndrome due to a de novo mutation typically do not carry the mutation themselves and have a very low risk of having another child with the condition.

However, in a smaller proportion of cases (less than 5%), Kabuki syndrome can be inherited. This occurs when one of the parents carries a mutation in one of the causative genes (like KMT2D or KMT2C) and passes it on to their child. In such cases, the inheritance pattern is usually autosomal dominant, meaning that only one copy of the altered gene is sufficient to cause the disorder. If a parent has an autosomal dominant condition, each child has a 50% chance of inheriting the altered gene and developing the condition.

Mechanism of Action

The proteins encoded by KMT2D and KMT2C are part of a larger complex that modifies chromatin, the structure of DNA and associated proteins within the cell nucleus. This complex acts as a 'histone methyltransferase,' adding methyl groups to specific sites on histone proteins. This modification is a key epigenetic mechanism that influences gene expression without altering the underlying DNA sequence itself. These genes are critical for establishing and maintaining proper gene expression patterns during embryonic development.

When mutations occur in KMT2D or KMT2C, the function of this epigenetic regulatory complex is impaired. This disruption leads to widespread abnormalities in gene expression across various tissues and organs. The precise downstream effects of these dysregulated genes are still being researched, but they are believed to contribute to the diverse range of developmental and physical characteristics observed in Kabuki syndrome, including the distinctive facial features, skeletal anomalies, cardiac defects, and cognitive impairments.

Diagnosis and Genetic Testing

The diagnosis of Kabuki syndrome is often suspected based on the presence of characteristic clinical features, including the distinctive facial appearance (e.g., prominent forehead, arched eyebrows, long palpebral fissures with eversion of the lateral third of the lower eyelid), developmental delay, intellectual disability, and other physical anomalies. However, due to the variability in presentation, diagnosis can sometimes be delayed or missed, especially in milder cases.

Genetic testing is the definitive method for confirming a diagnosis of Kabuki syndrome. This involves analyzing a blood sample from the individual to look for mutations in the KMT2D, KMT2C, and other known KS-associated genes. Advances in genetic technology, such as next-generation sequencing (NGS), have made it more efficient and accurate to identify these mutations. A positive genetic test result can provide a definitive diagnosis, help in genetic counseling for families, and potentially guide management strategies.

Implications for Families

For families receiving a diagnosis of Kabuki syndrome, understanding the cause is the first step in navigating the complexities of the condition. Genetic counseling can be invaluable in explaining the genetic basis, inheritance patterns, recurrence risks, and implications for family planning. While many cases are sporadic (de novo), identifying an inherited form is crucial for assessing risks for other family members.

The rarity of Kabuki syndrome means that affected individuals and their families may benefit from connecting with support groups and specialized medical centers that have experience in managing this complex disorder. Early intervention services, tailored educational programs, and multidisciplinary medical care are essential for optimizing the development and quality of life for individuals with Kabuki syndrome.